RYCVX
Price
$190.51
Change
-$0.02 (-0.01%)
Updated
Oct 8 closing price
Net Assets
39.99M
RYVLX
Price
$721.50
Change
+$16.52 (+2.34%)
Updated
Oct 8 closing price
Net Assets
1.45B
Interact to see
Advertisement

RYCVX vs RYVLX

Header iconRYCVX vs RYVLX Comparison
Open Charts RYCVX vs RYVLXBanner chart's image
Rydex Dow 2x Strategy H
Price$190.51
Change-$0.02 (-0.01%)
VolumeN/A
Net Assets39.99M
Rydex NASDAQ-100® 2x Strategy A
Price$721.50
Change+$16.52 (+2.34%)
VolumeN/A
Net Assets1.45B
RYCVX vs RYVLX Comparison Chart in %
View a ticker or compare two or three
VS
RYCVX vs. RYVLX commentary
Oct 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RYCVX is a Buy and RYVLX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RYVLX has more cash in the bank: 1.45B vs. RYCVX (40M). RYCVX pays higher dividends than RYVLX: RYCVX (0.55) vs RYVLX (0.00). RYCVX was incepted earlier than RYVLX: RYCVX (22 years) vs RYVLX (21 years). RYCVX (1.87) and RYVLX (1.87) have similar cost to investors . RYCVX is a more actively managed with annual turnover of: 1015.00 vs. RYVLX (383.00). RYCVX (2500) and RYVLX (2500) have matching initial minimum investment requirements. RYVLX annual gain was more profitable for investors over the last year : 29.97 vs. RYCVX (11.68). RYVLX return over 5 years is better than : 132.22 vs. RYCVX (99.98).
RYCVXRYVLXRYCVX / RYVLX
Total Expense Ratio1.771.74102%
Annual Report Gross Expense Ratio1.871.87100%
Fund Existence22 years21 years-
Gain YTD13.74228.04549%
Front LoadN/A5%-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets40M1.45B3%
Annual Yield % from dividends0.550.00-
Returns for 1 year11.6829.9739%
Returns for 3 years103.83254.1041%
Returns for 5 years99.98132.2276%
Returns for 10 years314.70858.1137%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LYSDY13.280.66
+5.23%
Lynas Rare Earths Limited
BKFKY12.38N/A
N/A
Bakkafrost PF
HGRVF7.33N/A
N/A
Hargreaves Services Plc
VPHIF0.05N/A
N/A
Valeo Pharma Inc.
AQUC12.10N/A
N/A
Aquaron Acquisition Corp.